Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex

Hui-qiang Huang, Gao Yan, Hang Su, Yunhong Huang, Yuhuan Gao, Wang Xiaoxiao, Bai Bing, Yujing Zhang, Liping Su, Xiaoxia Chu, Wenyu Li, MD PhD, Junyi Zhang, Qiaohua Zhang, MD, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang

Blood (2019) 134 (Supplement_1): 1569.

https://doi.org/10.1182/blood-2019-123478

Published: 2019

Journal Articles

Pegaspargase with Concurrent Radiotherapy in a Once-Every-Three-Weeks Schedule in Patients with Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: A Phase II Study

Hua Wang, MD, Wei Luo, Yue Lu

Blood (2018) 132 (Supplement 1): 2928.

https://doi.org/10.1182/blood-2018-99-113265

Published: 2018

Journal Articles

Chemotherapy of GEP Regimen(Gemcitabine,etoposide and Pegaspargase) for the Patients with Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma: a Phase II Clinical Trial

Hua Wang, PhD, Xiao-qin Chen, Wei-da Wang, Zhong-jun Xia, MD

Blood (2017) 130 (Supplement 1): 2787.

https://doi.org/10.1182/blood.V130.Suppl_1.2787.2787

Published: 2017

Journal Articles

Pegaspargase Plus Gemcitabine, Oxaliplatin(P-Gemox) and Thalidomide Versus Aspermetdex Regimen for the Patients with Early or Advanced/Relapsed Extranodal Natural Killer/T Cell Lymphoma: Interim Analysis of a Prospective,Multicenter, Randomized, Phase III Non-Inferiority Clinical Trial

Yan Gao, Huiqiang Huang, MD, Yujing Zhang, Hang Su, Xiaoxiao Wang, Bing Bai, Yunhong Huang, Yuhuan Gao, Liping Su, MD, Xiaoxia Chu, Wenyu Li, Junyi Zhang, Qiaohua Zhang, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang, MD PhD

Blood (2016) 128 (22): 1819.

https://doi.org/10.1182/blood.V128.22.1819.1819

Published: 2016

Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4646.

https://doi.org/10.1182/blood.V128.22.4646.4646

Published: 2016

Journal Articles

Blocking Stat3 to Regulate the Balance of Th17/Treg in Cgvhd Therapy

Jianyu Weng, Xin Huang, Xiaomei Chen, Qiong Luo, Jianhua Su, Jiaqi Tong, Zhi Cao, Peilong Lai, Suijing Wu, Chengwei Luo, Wei Ling, Xin Du

Blood (2015) 126 (23): 5420.

https://doi.org/10.1182/blood.V126.23.5420.5420

Published: 2015

Journal Articles

Longterm Outcome of Induction Chemotherapy of P-Gemox Regimen Followed By Extensive Involved-Field Radiotherapy(EIFRT) for Newly Diagnosed Stage I/II Extranodal Natural Killer/T-Cell Lymphoma---a Single Center Experience

Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Zheng Yan, Wenqi Jiang, Zhongjun Xia, MD, ZhiMing Li

Blood (2015) 126 (23): 3936.

https://doi.org/10.1182/blood.V126.23.3936.3936

Published: 2015

Journal Articles

Low-Dose Ionizing Radiation Modulates Expression of Gpam in Immortalized EBV Infected B Cells through miRNA Network

Yoko Tabe, MD PhD, Yasuhito Hatanaka, Mayumi Nakashiro, MD, Kazumasa Sekihara, PhD, Shinichi Yamamoto, PhD, Hiromichi Matsushita, MD PhD, Saiko Kazuno, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD, Keisuke Sasai, MD PhD, Takashi Miida, MDPhD

Blood (2015) 126 (23): 4829.

https://doi.org/10.1182/blood.V126.23.4829.4829

Published: 2015

Journal Articles

Extreme Heterogeneity Of Myeloablative Total Body Irradiation (TBI) Techniques Across Europe: A Survey Of Acute Leukemia Working Party Of The EBMT

Sebastian Giebel, MD, Leszek Miszczyk, MD, PhD, Krzysztof Slosarek, PhD, Leila Moukhtari, Fabio Ciceri, MD, Jordi Esteve, MD, PhD, Norbert Claude Gorin, MD, Myriam Labopin, MD, Arnon Nagler, MD, MSc, Christoph Schmid, MD, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 4565.

https://doi.org/10.1182/blood.V122.21.4565.4565

Published: 2013

Journal Articles

A New Murine Model Of Chronic Graft Versus Host Disease

Xin Huang, Jianyu Weng, M.D., Ping Wu, Jiaqi Tong, Peilong Lai, Suxia Geng, Xin Du, MD

Blood (2013) 122 (21): 5429.

https://doi.org/10.1182/blood.V122.21.5429.5429

Published: 2013

Journal Articles

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Nadim Mahmud, MD, PhD, David Peace, MD, John G. Quigley, MD, Santosh L. Saraf, MD, Enzo DeMasi, MD, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2013) 122 (21): 3285.

https://doi.org/10.1182/blood.V122.21.3285.3285

Published: 2013

Journal Articles

Integrative Genomic and Proteomic Analysis Of Low-Dose ionizing Irradiation Effects On Bone Marrow Stromal Microenvironment and On Survival Of Pre-Leukemic Cells

Yoko Tabe, MD, PhD, Linhua Jin, PhD, Yasuhito Hatanaka, Hiromichi Matsushita, MD, PhD, Saiko Kazuno, Tsutomu Fujimura, Takashi Ueno, Keisuke Sasai, Kazuhisa Iwabuchi, PhD, Michael Andreeff, MD, PhD, Marina Konopleva, MD, PhD, Takashi Miida, MD, PhD

Blood (2013) 122 (21): 3775.

https://doi.org/10.1182/blood.V122.21.3775.3775

Published: 2013

Journal Articles

Low Dose-Radiation of Bone Marrow Stromal Cells Supports Pre-Leukemic Cell Survival Via Adhesion and Inflammatory Signaling Stimulation

Yoko Tabe, MD, PhD, Linhua Jin, PhD, Yasuhito Hatanaka, Saiko Kazuno, Tsutomu Fujimura, Hiromichi Matsushita, MD, PhD, Takashi Ueno, Keisuke Sasai, Takashi Miida, MD, PhD

Blood (2012) 120 (21): 4610.

https://doi.org/10.1182/blood.V120.21.4610.4610

Published: 2012

Journal Articles

Continuous Decline in Second Malignancy Occurrence in Patients with Hodgkin Lymphoma; Analysis of 1670 Patients Over the Past 5 Decades

Bouthaina S. Dabaja, MD, Ferial Shihadeh, MD, Carol Etzel, PhD, Liang Fu-wen, MS, Shervin Mohajer Shirvani, MD, Leslie Ballas, MD, Pamela Allen, PhD, Maria A. Rodriguez, MD, Michelle A. Fanale, MD, Anas Younes, MD

Blood (2011) 118 (21): 2694.

https://doi.org/10.1182/blood.V118.21.2694.2694

Published: 2011

Journal Articles

Linac Based Total Marrow Irradiation and Myeloablative Chemotherapy In Allogeneic Stem Cell Transplantation for High Risk Patients.

Pritesh R. Patel, MB, ChB, Bulent Aydogan, PhD, Damiano Rondelli, MD

Blood (2010) 116 (21): 4526.

https://doi.org/10.1182/blood.V116.21.4526.4526

Published: 2010

Journal Articles

Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression After Conditioning with Fludarabine and Low-Dose Total Body Irradiation for Recipients of HLA-Matched Sibling or Unrelated Donor Hematopoietic Cell Transplants in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Tara Gregory, MD, Mark W. Brunvand, MD, Peter A. McSweeney, MD, Scott I. Bearman, MD, Michael Maris, MD, Jeffrey Matous, MD

Blood (2009) 114 (22): 3354.

https://doi.org/10.1182/blood.V114.22.3354.3354

Published: 2009

NARROW

Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex

Pegaspargase with Concurrent Radiotherapy in a Once-Every-Three-Weeks Schedule in Patients with Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: A Phase II Study

Chemotherapy of GEP Regimen(Gemcitabine,etoposide and Pegaspargase) for the Patients with Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma: a Phase II Clinical Trial

Pegaspargase Plus Gemcitabine, Oxaliplatin(P-Gemox) and Thalidomide Versus Aspermetdex Regimen for the Patients with Early or Advanced/Relapsed Extranodal Natural Killer/T Cell Lymphoma: Interim Analysis of a Prospective,Multicenter, Randomized, Phase III Non-Inferiority Clinical Trial

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Blocking Stat3 to Regulate the Balance of Th17/Treg in Cgvhd Therapy

Longterm Outcome of Induction Chemotherapy of P-Gemox Regimen Followed By Extensive Involved-Field Radiotherapy(EIFRT) for Newly Diagnosed Stage I/II Extranodal Natural Killer/T-Cell Lymphoma---a Single Center Experience

Low-Dose Ionizing Radiation Modulates Expression of Gpam in Immortalized EBV Infected B Cells through miRNA Network

Extreme Heterogeneity Of Myeloablative Total Body Irradiation (TBI) Techniques Across Europe: A Survey Of Acute Leukemia Working Party Of The EBMT

A New Murine Model Of Chronic Graft Versus Host Disease

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Integrative Genomic and Proteomic Analysis Of Low-Dose ionizing Irradiation Effects On Bone Marrow Stromal Microenvironment and On Survival Of Pre-Leukemic Cells

Low Dose-Radiation of Bone Marrow Stromal Cells Supports Pre-Leukemic Cell Survival Via Adhesion and Inflammatory Signaling Stimulation

Continuous Decline in Second Malignancy Occurrence in Patients with Hodgkin Lymphoma; Analysis of 1670 Patients Over the Past 5 Decades

Linac Based Total Marrow Irradiation and Myeloablative Chemotherapy In Allogeneic Stem Cell Transplantation for High Risk Patients.

Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression After Conditioning with Fludarabine and Low-Dose Total Body Irradiation for Recipients of HLA-Matched Sibling or Unrelated Donor Hematopoietic Cell Transplants in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only